Former STAR PhD Fellow
Current position: Vice President
In 2000 I was employed at Novo Nordisk A/S as a research scientist.
Being a doctor of veterinary medicine, with seven years of experience
from a clinical practice and five years from another pharmaceutical
company I had never really had the time to do a PhD. The STAR
programme changed that by providing me with the funding to be enrolled
as a PhD student at the University of Copenhagen, while holding a
position as research scientist. My work was characterized by research
support in existing projects in combination with protocols and
intensive lab work to provide data for the hypothesis in my PhD
project, which investigated the effects of recombinant activated
factor VII (rFVIIa) in experimental models of haemostasis.
Thinking back on that time it was lots of fun. Multiple activities
were going on at the same time - including the management of 4-5
technicians. I enjoyed working in the lab, getting hands-on experience
and engaging in direct problem solving. At the same time this period
was characterized by intense networking including internal and
external collaborations. After two and half years I was able to submit
my PhD thesis including four papers, of which two were published in
peer-reviewed journals. At the same time I was appointed manager of a
new research department specifically defined to work with pharmacology
in haemostasis. At that time we were eight people in the department.
Now - almost six years later – we are 22 employees.
My burning passion is research, but over the years my focus has changed from being a specialist and active research scientist to more managerial tasks. I have successfully supervised one PhD student (funded by the STAR programme) and she is now employed in my department. The STAR funding gave me the opportunity to obtain my PhD in invivo pharmacology and led the way to my present position heading a research department at Novo Nordisk.
Mads Krogsgaard Thomsen, Chief Science Officer at Novo Nordisk, talks about the need to attract the best scientific talent from around the world.
Read more about our R&D strategy and research pipeline and our
latest research publications at our dedicated